This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Hadasit Medical Research Services and Development Company, Hadasit Medical Research Services and Development Ltd., Pharmacia Ab. Active years: 1997-2011.
Company Filing History:
1 out of 31 
1 out of 180 
1 out of 184 
Years Active: 1997-2011
Title: The Innovative Contributions of Lola Weiss
Introduction
Lola Weiss is a prominent inventor based in Jerusalem, Israel. She has made significant strides in the field of medical research, particularly in the treatment and prevention of diabetes. With a total of 3 patents to her name, her work has garnered attention for its potential impact on diabetes management.
Latest Patents
Weiss's latest patents include groundbreaking research on the use of cannabidiol for treating or preventing diabetes. One of her notable inventions is a medicament identified for the treatment or prevention of diabetes and/or insulitis. Additionally, she has developed a composition for diabetes treatment that includes an immunoregulator, preferably Linomide, and a beta cell proliferative agent, which has shown effectiveness in both inhibiting the progression of diabetes and reversing the disease's course in the NOD mouse model.
Career Highlights
Throughout her career, Weiss has been associated with reputable organizations such as Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Hadasit Medical Research Services and Development Ltd. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Weiss has collaborated with esteemed colleagues, including Shimon Slavin and David Gross. These partnerships have further enriched her research endeavors and expanded the scope of her innovations.
Conclusion
Lola Weiss's contributions to diabetes research through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in treatment options for diabetes, showcasing the importance of innovation in healthcare.